Ideaya Biosciences (IDYA)CEO sold ~$31K

~$31K

Approx. value · 800 sh @ $38.26

691K

Holds after · shares reported

Traded

Oct 6, 2026

Filed

Oct 8, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Oct 6, 2026 · this disclosureInsiderCEO sold ~$31K of IDYA shares in the open market

What came next

1. Oct 6, 2026InsiderCEO sold ~$955K of IDYA shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Ideaya Biosciences

For Ideaya Biosciences, OQRO holds 3 insider filings (SEC Form 4 or Form 144) and 3 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its IDYA page.

Other recent filings by Yujiro S Hata, President and CEO

• SEC Form 4 at Ideaya Biosciences (IDYA)Oct 8, 2026

The full history of Yujiro S Hata, President and CEO is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Ideaya Biosciences

• SEC Form 4Oct 8, 2026
• SEC Form 144Oct 6, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 7, 2026
• SEC Form 13F-HRMay 15, 2026

Everything OQRO holds on this company is on its IDYA page.